<DOC>
	<DOCNO>NCT00003040</DOCNO>
	<brief_summary>RATIONALE : Laser surgery cancer larynx may fewer side effect improve recovery . Radiation therapy use high-energy x-rays damage tumor cell . Combining radiation therapy laser surgery may kill tumor cell . PURPOSE : Phase II trial study effectiveness laser surgery plus radiation therapy treat patient early stage cancer larynx .</brief_summary>
	<brief_title>S9709 , Laser Surgery Plus Radiation Therapy Treating Patients With Early Stage Cancer Larynx</brief_title>
	<detailed_description>OBJECTIVES : I. Assess feasibility treat untreated stage I , II select stage III squamous cell carcinoma supraglottic larynx endoscopic surgery irradiation . II . Estimate 3 year progression free survival describe location disease progression . OUTLINE : Patients receive carbon dioxide laser laryngectomy within 28 day follow protocol registration . Patients N1 disease may undergo optional neck dissection ipsilateral neck mass . Neck dissection include complete removal least lymph node level 2-4 . Radiation therapy begin 14 day follow laser surgery . Patients follow every 3 month first year , every 6 month second year , every 12 month thereafter death . PROJECTED ACCRUAL : There 50 patient accrue study 3 year estimate accrual rate 20 patient per year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven , newly diagnose , untreated stage I , II , select stage III ( T1T2 , N1 , M0 ) squamous cell carcinoma supraglottic larynx Bidimensionally measurable disease No metastatic stage III T3 disease No immediate lifethreatening complication disease PATIENT CHARACTERISTICS : Age : Over 18 Performance status : SWOG 0 1 Life expectancy : Not specify Hematopoietic : WBC great 3,500/mm3 Platelet count great 50,000/mm3 Hemoglobin great 10.0 g/dL Hepatic : Not specify Renal : Not specify Cardiovascular : At least 3 month since prior myocardial infarction No uncontrolled congestive heart failure No unstable uncontrolled angina Other : No prior malignancy except follow : Adequately treat basal cell squamous cell skin cancer In situ cervical cancer Other cancer patient diseasefree least five year No history prior laryngeal cancer No history primary tumor aerodigestive tract site except disease site All fertile patient must use effective contraceptive method Must medically able undergo general anesthesia No psychological , familial , sociological geographical condition permit medical followup compliance study protocol No unstable preexist major medical condition PRIOR CONCURRENT THERAPY : No prior treatment squamous cell carcinoma supraglottic larynx</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
</DOC>